Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/230718
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma |
Autor: | Garcés, Juan José; Bretones, Gabriel CSIC ORCID; Burgos, Leire; Valdes-Mas, Rafael; Puig, Noemi; Cedena, Maria-Teresa; Alignani, Diego; Rodríguez, Idoia; Álvarez Puente, Diana; García Álvarez, Miguel; Goicoechea, Ibai; Rodríguez, Sara; Calasanz, Mª Jose; Agirre, Xavier; Flores-Montero, Juan; Sanoja-Flores, Luzalba CSIC ORCID; Rodríguez-Otero, Paula; Ríos, Rafael; Martínez-López, Joaquín; Millacoy, Pamela; Palomera, Luis; Orbe, Rafael del; Pérez-Montaña, Albert; Omri, Halima El; Prósper, Felipe; Mateos, Maria Victoria; Rosiñol, Laura; Bladé, Joan; Lahuerta, Juan José; Orfao, Alberto CSIC ORCID ; López-Otín, Carlos CSIC ORCID; Miguel, Jesus F. San; Paiva, Bruno | Palabras clave: | Cancer genomics Genetic testing Metastasis Translational research |
Fecha de publicación: | 2020 | Editor: | Springer Nature | Citación: | Leukemia 34: 3007-3018 (2020) | Resumen: | Multiple myeloma (MM) patients undergo repetitive bone marrow (BM) aspirates for genetic characterization. Circulating tumor cells (CTCs) are detectable in peripheral blood (PB) of virtually all MM cases and are prognostic, but their applicability for noninvasive screening has been poorly investigated. Here, we used next-generation flow (NGF) cytometry to isolate matched CTCs and BM tumor cells from 53 patients and compared their genetic profile. In eight cases, tumor cells from extramedullary (EM) plasmacytomas were also sorted and whole-exome sequencing was performed in the three spatially distributed tumor samples. CTCs were detectable by NGF in the PB of all patients with MM. Based on the cancer cell fraction of clonal and subclonal mutations, we found that ~22% of CTCs egressed from a BM (or EM) site distant from the matched BM aspirate. Concordance between BM tumor cells and CTCs was high for chromosome arm-level copy number alterations (≥95%) though not for translocations (39%). All high-risk genetic abnormalities except one t(4;14) were detected in CTCs whenever present in BM tumor cells. Noteworthy, ≥82% mutations present in BM and EM clones were detectable in CTCs. Altogether, these results support CTCs for noninvasive risk-stratification of MM patients based on their numbers and genetic profile. | Versión del editor: | http://dx.doi.org/10.1038/s41375-020-0883-0 | URI: | http://hdl.handle.net/10261/230718 | DOI: | 10.1038/s41375-020-0883-0 | ISSN: | 0887-6924 | E-ISSN: | 1476-5551 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
28
checked on 18-abr-2024
WEB OF SCIENCETM
Citations
26
checked on 24-feb-2024
Page view(s)
133
checked on 24-abr-2024
Download(s)
33
checked on 24-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.